Uncategorized - November 30, 2016
29-30 November 2016: Biolatam
Discover the richness of Latin America Biolatam is the biotechnology conference which provides unique access to Latin America, one of the fastest growing life science markets, in a forum for collaboration, discussion and partnering among key industry executives in Latin America, the US and Europe. International drug developers are increasingly targeting Latin America’s emerging market […]
Drug Development Pharma - January 21, 2014
MVA Ambassador contributes to CBS report about pharmaceutical public-private partnering
MVA Ambassador Torsten Jepsen, responsible for the U.S. East Coast, played a key role in developing a new report by Copenhagen Business School (CBS), which examines the growing trend of pharmaceutical companies teaming up with universities to boost innovation and speed up drug discovery. The report, entitled “Value and growth through new kinds of innovative […]
Drug Development Pharma - January 7, 2014
International pharmaceutical breakthrough backed by public funding
A multi-billion kroner agreement on a new pain-relief medication has been signed between the Norwegian innovation company, Inven2, and the pharmaceuticals giant, Merck. Public funding has played an important role in the Norwegian researchers’ success. The agreement confirms the vast potential of Norwegian health research. There are many outstanding researchers carrying out innovative basic and […]
